MedTrace Logo

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

NCT01853696 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2015-05-15

Study results available
· View outcomes & findings →

Summary

Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticosteroid dosing regimens after endothelial keratoplasty (cornea transplant) surgery.

Conditions

  • Fuchs' Dystrophy
  • Corneal Edema

Interventions

DRUG

loteprednol etabonate

DRUG

prednisolone acetate 1%

Sponsors & Collaborators

  • Cornea Research Foundation of America

    lead OTHER

Principal Investigators

  • Francis W Price, Jr., MD · Price Vision Group

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01853696 on ClinicalTrials.gov